5 years ago

biotechdispatch.com.au

Bod Australia reports first prescriptions in the UK

5 years ago

biotechdispatch.com.au

Pharmaxis appoints US-based director

5 years ago

nextbiotech.com.au

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

5 years ago

fool.com.au

These ASX cloud computing shares could provide strong returns for investors

5 years ago

sharecafe.com.au

Overnight: Fierce Resilience

5 years ago

finfeed.com

Exore's 530,000 ounce maiden gold resource suggests plenty of upside to come

5 years ago

proactiveinvestors.com.au

Nelson Resources develops clear model to guide future exploration

5 years ago

fnarena.com

The Overnight Report: Fierce Resilience

5 years ago

proactiveinvestors.com.au

Oakdale Resources launches entitlement offer to raise up to $1.4 million

5 years ago

fool.com.au

An instant 6 share diversified portfolio for ASX investors